Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Albumin
1.2.3 Factor VIII
1.2.4 Factor IX
1.2.5 Immunoglobulin
1.2.6 Hyperimmune Globulin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Derivatives Market Perspective (2018-2034)
2.2 Blood Plasma Derivatives Growth Trends by Region
2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2018-2024)
2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2024-2034)
2.3 Blood Plasma Derivatives Market Dynamics
2.3.1 Blood Plasma Derivatives Industry Trends
2.3.2 Blood Plasma Derivatives Market Drivers
2.3.3 Blood Plasma Derivatives Market Challenges
2.3.4 Blood Plasma Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Derivatives Players by Revenue
3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2018-2024)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2018-2024)
3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue
3.4 Global Blood Plasma Derivatives Market Concentration Ratio
3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2022
3.5 Blood Plasma Derivatives Key Players Head office and Area Served
3.6 Key Players Blood Plasma Derivatives Product Solution and Service
3.7 Date of Enter into Blood Plasma Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Derivatives Breakdown Data by Type
4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2018-2024)
4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2034)
5 Blood Plasma Derivatives Breakdown Data by Application
5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2018-2024)
5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Blood Plasma Derivatives Market Size (2018-2034)
6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Blood Plasma Derivatives Market Size by Country (2018-2024)
6.4 North America Blood Plasma Derivatives Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size (2018-2034)
7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Blood Plasma Derivatives Market Size by Country (2018-2024)
7.4 Europe Blood Plasma Derivatives Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2018-2034)
8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2024)
8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size (2018-2034)
9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Blood Plasma Derivatives Market Size by Country (2018-2024)
9.4 Latin America Blood Plasma Derivatives Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2018-2034)
10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2024)
10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Plasma Derivatives Introduction
11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2018-2024)
11.1.5 Grifols Recent Development
11.2 SK Plasma
11.2.1 SK Plasma Company Detail
11.2.2 SK Plasma Business Overview
11.2.3 SK Plasma Blood Plasma Derivatives Introduction
11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2018-2024)
11.2.5 SK Plasma Recent Development
11.3 Fusion Health Care
11.3.1 Fusion Health Care Company Detail
11.3.2 Fusion Health Care Business Overview
11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction
11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2018-2024)
11.3.5 Fusion Health Care Recent Development
11.4 Biotest AG
11.4.1 Biotest AG Company Detail
11.4.2 Biotest AG Business Overview
11.4.3 Biotest AG Blood Plasma Derivatives Introduction
11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2018-2024)
11.4.5 Biotest AG Recent Development
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Detail
11.5.2 Green Cross Corporation Business Overview
11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction
11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2018-2024)
11.5.5 Green Cross Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Blood Plasma Derivatives Introduction
11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2018-2024)
11.6.5 Baxter International Recent Development
11.7 LFB
11.7.1 LFB Company Detail
11.7.2 LFB Business Overview
11.7.3 LFB Blood Plasma Derivatives Introduction
11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2018-2024)
11.7.5 LFB Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Detail
11.8.2 Octapharma AG Business Overview
11.8.3 Octapharma AG Blood Plasma Derivatives Introduction
11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2018-2024)
11.8.5 Octapharma AG Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Company Detail
11.9.2 CSL Limited Business Overview
11.9.3 CSL Limited Blood Plasma Derivatives Introduction
11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2018-2024)
11.9.5 CSL Limited Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Blood Plasma Derivatives Introduction
11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2018-2024)
11.10.5 Takeda Recent Development
11.11 China Biologic Products
11.11.1 China Biologic Products Company Detail
11.11.2 China Biologic Products Business Overview
11.11.3 China Biologic Products Blood Plasma Derivatives Introduction
11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2018-2024)
11.11.5 China Biologic Products Recent Development
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Company Detail
11.12.2 Kedrion Biopharma Business Overview
11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction
11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2018-2024)
11.12.5 Kedrion Biopharma Recent Development
11.13 BDI Pharma
11.13.1 BDI Pharma Company Detail
11.13.2 BDI Pharma Business Overview
11.13.3 BDI Pharma Blood Plasma Derivatives Introduction
11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2018-2024)
11.13.5 BDI Pharma Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Detail
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Blood Plasma Derivatives Introduction
11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2018-2024)
11.14.5 Bayer AG Recent Development
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Company Detail
11.15.2 Hualan Biological Engineering Business Overview
11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction
11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2018-2024)
11.15.5 Hualan Biological Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Albumin
Table 3. Key Players of Factor VIII
Table 4. Key Players of Factor IX
Table 5. Key Players of Immunoglobulin
Table 6. Key Players of Hyperimmune Globulin
Table 7. Key Players of Others
Table 8. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 9. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 10. Global Blood Plasma Derivatives Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Blood Plasma Derivatives Market Share by Region (2018-2024)
Table 12. Global Blood Plasma Derivatives Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global Blood Plasma Derivatives Market Share by Region (2024-2034)
Table 14. Blood Plasma Derivatives Market Trends
Table 15. Blood Plasma Derivatives Market Drivers
Table 16. Blood Plasma Derivatives Market Challenges
Table 17. Blood Plasma Derivatives Market Restraints
Table 18. Global Blood Plasma Derivatives Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Blood Plasma Derivatives Market Share by Players (2018-2024)
Table 20. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2022)
Table 21. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2018-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Blood Plasma Derivatives Product Solution and Service
Table 25. Date of Enter into Blood Plasma Derivatives Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Blood Plasma Derivatives Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2018-2024)
Table 29. Global Blood Plasma Derivatives Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global Blood Plasma Derivatives Revenue Market Share by Type (2024-2034)
Table 31. Global Blood Plasma Derivatives Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2018-2024)
Table 33. Global Blood Plasma Derivatives Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2024-2034)
Table 35. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. North America Blood Plasma Derivatives Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Blood Plasma Derivatives Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 39. Europe Blood Plasma Derivatives Market Size by Country (2018-2024) & (US$ Million)
Table 40. Europe Blood Plasma Derivatives Market Size by Country (2024-2034) & (US$ Million)
Table 41. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2018-2024) & (US$ Million)
Table 43. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2024-2034) & (US$ Million)
Table 44. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Latin America Blood Plasma Derivatives Market Size by Country (2018-2024) & (US$ Million)
Table 46. Latin America Blood Plasma Derivatives Market Size by Country (2024-2034) & (US$ Million)
Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 48. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2024-2034) & (US$ Million)
Table 50. Grifols Company Detail
Table 51. Grifols Business Overview
Table 52. Grifols Blood Plasma Derivatives Product
Table 53. Grifols Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 54. Grifols Recent Development
Table 55. SK Plasma Company Detail
Table 56. SK Plasma Business Overview
Table 57. SK Plasma Blood Plasma Derivatives Product
Table 58. SK Plasma Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 59. SK Plasma Recent Development
Table 60. Fusion Health Care Company Detail
Table 61. Fusion Health Care Business Overview
Table 62. Fusion Health Care Blood Plasma Derivatives Product
Table 63. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 64. Fusion Health Care Recent Development
Table 65. Biotest AG Company Detail
Table 66. Biotest AG Business Overview
Table 67. Biotest AG Blood Plasma Derivatives Product
Table 68. Biotest AG Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 69. Biotest AG Recent Development
Table 70. Green Cross Corporation Company Detail
Table 71. Green Cross Corporation Business Overview
Table 72. Green Cross Corporation Blood Plasma Derivatives Product
Table 73. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 74. Green Cross Corporation Recent Development
Table 75. Baxter International Company Detail
Table 76. Baxter International Business Overview
Table 77. Baxter International Blood Plasma Derivatives Product
Table 78. Baxter International Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 79. Baxter International Recent Development
Table 80. LFB Company Detail
Table 81. LFB Business Overview
Table 82. LFB Blood Plasma Derivatives Product
Table 83. LFB Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 84. LFB Recent Development
Table 85. Octapharma AG Company Detail
Table 86. Octapharma AG Business Overview
Table 87. Octapharma AG Blood Plasma Derivatives Product
Table 88. Octapharma AG Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 89. Octapharma AG Recent Development
Table 90. CSL Limited Company Detail
Table 91. CSL Limited Business Overview
Table 92. CSL Limited Blood Plasma Derivatives Product
Table 93. CSL Limited Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 94. CSL Limited Recent Development
Table 95. Takeda Company Detail
Table 96. Takeda Business Overview
Table 97. Takeda Blood Plasma Derivatives Product
Table 98. Takeda Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 99. Takeda Recent Development
Table 100. China Biologic Products Company Detail
Table 101. China Biologic Products Business Overview
Table 102. China Biologic Products Blood Plasma Derivatives Product
Table 103. China Biologic Products Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 104. China Biologic Products Recent Development
Table 105. Kedrion Biopharma Company Detail
Table 106. Kedrion Biopharma Business Overview
Table 107. Kedrion Biopharma Blood Plasma Derivatives Product
Table 108. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 109. Kedrion Biopharma Recent Development
Table 110. BDI Pharma Company Detail
Table 111. BDI Pharma Business Overview
Table 112. BDI Pharma Blood Plasma Derivatives Product
Table 113. BDI Pharma Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 114. BDI Pharma Recent Development
Table 115. Bayer AG Company Detail
Table 116. Bayer AG Business Overview
Table 117. Bayer AG Blood Plasma Derivatives Product
Table 118. Bayer AG Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 119. Bayer AG Recent Development
Table 120. Hualan Biological Engineering Company Detail
Table 121. Hualan Biological Engineering Business Overview
Table 122. Hualan Biological Engineering Blood Plasma Derivatives Product
Table 123. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2018-2024) & (US$ Million)
Table 124. Hualan Biological Engineering Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Plasma Derivatives Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Blood Plasma Derivatives Market Share by Type: 2022 VS 2034
Figure 3. Albumin Features
Figure 4. Factor VIII Features
Figure 5. Factor IX Features
Figure 6. Immunoglobulin Features
Figure 7. Hyperimmune Globulin Features
Figure 8. Others Features
Figure 9. Global Blood Plasma Derivatives Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Blood Plasma Derivatives Market Share by Application: 2022 VS 2034
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Other End Users Case Studies
Figure 14. Blood Plasma Derivatives Report Years Considered
Figure 15. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Blood Plasma Derivatives Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Blood Plasma Derivatives Market Share by Region: 2022 VS 2034
Figure 18. Global Blood Plasma Derivatives Market Share by Players in 2022
Figure 19. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2022
Figure 21. North America Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Blood Plasma Derivatives Market Share by Country (2018-2034)
Figure 23. United States Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Blood Plasma Derivatives Market Share by Country (2018-2034)
Figure 27. Germany Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2018-2034)
Figure 35. China Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Blood Plasma Derivatives Market Share by Country (2018-2034)
Figure 43. Mexico Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2018-2034)
Figure 47. Turkey Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 50. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 51. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 52. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 53. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 54. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 55. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 56. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 57. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 58. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 59. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 60. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 61. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 62. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 63. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed